Impact of Project Wolbachia - Singapore on Dengue Incidence
Assessing the Efficacy of Male Wolbachia-infected Mosquito Deployments to Reduce Dengue Incidence in Singapore: a Cluster Randomized Controlled Trial
1 other identifier
interventional
724,428
1 country
1
Brief Summary
The study is a cluster-randomised controlled trial set in Singapore, to assess if the deployment of male Wolbachia-infected Aedes aegypti mosquitoes can reduce dengue incidence in intervention clusters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2022
CompletedStudy Start
First participant enrolled
July 28, 2022
CompletedFirst Posted
Study publicly available on registry
August 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 13, 2024
CompletedMay 22, 2025
May 1, 2025
2.1 years
July 19, 2022
May 19, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Odds ratio of Wolbachia exposure distribution among laboratory-confirmed reported dengue cases compared to test-negative controls
Dengue cases and dengue test-negative controls data will be obtained from the national surveillance network of diagnostic laboratories which receive samples for dengue testing.
Up to 3 years
Laboratory-confirmed reported dengue case counts normalized by population size in intervention versus non-intervention clusters
Dengue cases data will be obtained from the national surveillance network of diagnostic laboratories which receive samples for dengue testing.
Up to 3 years
Secondary Outcomes (2)
Prevalence of Ae. aegypti/Ae. albopictus mosquitoes
Up to 3 years
Public Attitudes, Perceptions & Knowledge (APK) of Wolbachia and other vector control interventions
Up to 3 years
Study Arms (2)
Intervention clusters
EXPERIMENTALResidential areas that receive releases of male Wolbachia-infected Aedes aegypti
Non-intervention clusters
NO INTERVENTIONResidential areas that do not receive releases of male Wolbachia-infected Aedes aegypti
Interventions
Releases of male Wolbachia-infected Aedes aegypti mosquitoes
Eligibility Criteria
You may qualify if:
- Dengue-suspected patients living in the intervention and non-intervention clusters whose blood samples are collected by a national network of diagnostic laboratories that support private clinics, public polyclinics, or public/private hospitals.
- Test positive cases: Patients with virologically confirmed DENV infection through RT-qPCR, testing positive for NS1 antigen or IgM. A positive test for any of the three assays would classify the patient as a dengue case.
- Test negative controls: Patients with negative test results for DENV through RT-qPCR, NS1 antigen ELISA, or DENV IgM.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Environment Agency
Singapore, Singapore
Related Publications (4)
Anders KL, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Andari B, Jewell NP, Rances E, O'Neill SL, Simmons CP, Utarini A. The AWED trial (Applying Wolbachia to Eliminate Dengue) to assess the efficacy of Wolbachia-infected mosquito deployments to reduce dengue incidence in Yogyakarta, Indonesia: study protocol for a cluster randomised controlled trial. Trials. 2018 May 31;19(1):302. doi: 10.1186/s13063-018-2670-z.
PMID: 29855331BACKGROUNDUtarini A, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Ansari MR, Supriyati E, Wardana DS, Meitika Y, Ernesia I, Nurhayati I, Prabowo E, Andari B, Green BR, Hodgson L, Cutcher Z, Rances E, Ryan PA, O'Neill SL, Dufault SM, Tanamas SK, Jewell NP, Anders KL, Simmons CP; AWED Study Group. Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue. N Engl J Med. 2021 Jun 10;384(23):2177-2186. doi: 10.1056/NEJMoa2030243.
PMID: 34107180BACKGROUNDLim JT, Mailepessov D, Chong CS, Chang CC, Dickens B, Lai YL, Deng L, Lee C, Tan LY, Chain G, Ho SH, Zulkifli MF, Liew J, Vasquez K, Lee V, Wong JCC, Sim S, Tan CH, Ng LC. Update to: Assessing the efficacy of male Wolbachia-infected mosquito deployments to reduce dengue incidence in Singapore. Trials. 2024 Jun 20;25(1):400. doi: 10.1186/s13063-024-08148-z.
PMID: 38902790DERIVEDOng J, Ho SH, Soh SXH, Wong Y, Ng Y, Vasquez K, Lai YL, Setoh YX, Chong CS, Lee V, Wong JCC, Tan CH, Sim S, Ng LC, Lim JT. Assessing the efficacy of male Wolbachia-infected mosquito deployments to reduce dengue incidence in Singapore: study protocol for a cluster-randomized controlled trial. Trials. 2022 Dec 17;23(1):1023. doi: 10.1186/s13063-022-06976-5.
PMID: 36528590DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lee Ching Ng, PhD
Group Director (Environmental Health Institute)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Group Director (Environmental Health Institute)
Study Record Dates
First Submitted
July 19, 2022
First Posted
August 18, 2022
Study Start
July 28, 2022
Primary Completion
September 13, 2024
Study Completion
September 13, 2024
Last Updated
May 22, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share